Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Biomarkers

Get Updates

Biomarkers research articles, Biomarkers research article, Biomarkers journals, Biomarkers journal, Biomarkers articles, Research on Breast cancer, Biomarkers



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Interview with Clinical Medicine Insights: Oncology editorial board member Prof. M. Wasif Saif
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010
  • Author interview with Dr Yoshihito Yokoyama
  • - 11/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
50
Articles published:
0
Comments:
23
Blog entries:

Journal: Biomarker Insights

Editor in Chief: Stephen F Kingsmore   |   Table of contents   |   270533 views
Get Updates
Get Updates

Journal: Biomarkers in Cancer

Editor in Chief: Dr Barbara Guinn   |   Table of contents   |   15273 views
Get Updates
Get Updates
Abstract
Full-text PDF

Feasibility of High-Throughput Genome-Wide Genotyping using DNA from Stored Buccal Cell Samples     (20/May/2010)


It is unclear if buccal cell samples contain sufficient human DNA with adequately sized fragments for high throughput genetic bioassays. Yet buccal cell sample collection is an attractive alternative to gathering blood samples for genetic epidemiologists engaged in large-scale genetic biomarker studies. We assessed the genotyping efficiency (GE) and genotyping...


Abstract
Full-text PDF

Validation of a Blood-Based Laboratory Test to Aid in the Confirmation of a Diagnosis of Schizophrenia     (12/May/2010)


We describe the validation of a serum-based test developed by Rules-Based Medicine which can be used to help confirm the diagnosis of schizophrenia. In preliminary studies using multiplex immunoassay profiling technology, we identified a disease signature comprised of 51 analytes which could distinguish schizophrenia (n = 250) from control (n...


Abstract
Full-text PDF

Elevated Serum Sorbitol and not Fructose in Type 2 Diabetic Patients     (04/May/2010)


Reductions in fasting serum fructose or erythrocyte sorbitol have been proposed as markers for early proof of mechanism in clinical development of aldose reductase (AR) inhibitors. However fructose is significantly impacted by meals and evaluation of erythrocyte sorbitol poses technical challenges. To more accurately assess the performance of these markers...


Abstract
Full-text PDF

The Common FTO Genetic Polymorphism rs9939609 is Associated with Increased BMI in Type 1 Diabetes  but not with Diabetic Nephropathy     (27/Apr/2010)


The fat mass and obesity associated (FTO) gene has an important genetic effect on body mass index (BMI) and risk of obesity, and obesity contributes to the progression of renal diseases, including diabetic nephropathy. We thus conducted a genetic association study to evaluate whether the FTO gene confers the...


Article: Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
Full-text PDFAbstract

Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance     (20/Apr/2010)


The use of biomarkers ensures breast cancer patients receive optimal treatment. Established biomarkers such as estrogen receptor (ER) and progesterone receptor (PR) have been playing significant roles in the selection and management of patients for endocrine therapy. HER2 is a strong predictor of response to trastuzumab. Recently, the roles of ER as a negative and HER2 as a positive indicator for chemotherapy have been established. Ki67 has traditionally been recognized as a poor prognostic factor,...


Abstract
Full-text PDF

EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups     (08/Apr/2010)


Objective: The early detection of NSCLC is of importance because it provides chances for better outcomes. The aim of the study was to explore the clinical utility of EGFR and hTERT mRNA expression as markers for diagnosis of NSCLC. Methods: EGFR and hTERT mRNA were quantified by quantative reverse transcription...


Abstract
Pay-per-view

Metastatic Colorectal Cancer: Focus on Panitumumab     (30/Mar/2010)


Biologic agents designed as targeted therapy are at the forefront of research in the field of colorectal cancer. Monoclonal antibodies targeting the epidermal growth factor receptor (EGFR) represent one such form of treatment, and the novel agent panitumumab is the first fully-human monoclonal antibody developed in this class. This drug...


Abstract
Full-text PDF

Protein-protein Interaction Reveals Synergistic Discrimination of Cancer Phenotype     (26/Mar/2010)


Cancer is a disease associated with the deregulation of multiple gene networks. Microarray data has permitted researchers to identify gene panel markers for diagnosis or prognosis of cancer but these are not sufficient to make specific mechanistic assertions about phenotype switches. We propose a strategy to identify putative mechanisms of...


Abstract
Full-text PDF

Identification of Gene Networks Associated with Acute Myeloid Leukemia by Comparative Molecular Methylation and Expression Profiling     (17/Mar/2010)


Around 80% of acute myeloid leukemia (AML) patients achieve a complete remission, however many will relapse and ultimately die of their disease. The association between karyotype and prognosis has been studied extensively and identified patient cohorts as having favourable [e.g. t(8; 21), inv (16)/t(16; 16), t(15; 17)], intermediate [e.g. cytogenetically...


Article: A Novel Strategy for Mechanism Based Computational Drug Discovery
Full-text PDFAbstract

A Novel Strategy for Mechanism Based Computational Drug Discovery     (10/Mar/2010)


Glioma, the common brain tumor, which arises from the glial cells, offers worse prognosis and therapy than any other tumors. Despite the genetic and pathological diversities of malignant gliomas, common signaling pathways that drive cellular proliferation, survival, invasion and angiogenesis have been identified. Very often, various tyrosine kinase receptors are inappropriately activated in human brain tumors and contribute to tumor malignancy. During such tumourous states where multiple pathways are involved, a few of them are...


Abstract
Full-text PDF

Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples     (18/Feb/2010)


Prostate cancer is the second most common cancer and the second leading cause of cancer death in men. However, prostate cancer can be effectively treated and cured, if it is diagnosed in its early stages when the tumor is still confined to the prostate. Combined with the digital rectal examination,...


Abstract
Full-text PDF

Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China     (12/Feb/2010)


Studies investigating possible associations between cytochrome P4501B1 (CYP1B1) polymorphisms and breast cancer risk have been inconsistent. We set out to ascertain whether there might be an association between polymorphisms in exon 2 (codon 119, G→T) and exon 3 (codon 432, G→C) of CYP1B1 and breast cancer in a Chinese Han...


Article: Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma
Full-text PDFAbstract

Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma     (11/Feb/2010)


A significant group of patient with estrogen receptor (ER) α positive breast tumors fails to appreciably respond to endocrine therapy. An increased understanding of the molecular basis of estrogen-mediated signal transduction and resultant gene expression may lead to novel strategies for treating breast cancer. In this study, we sought to identify the dysregulated genes in breast tumors related to ERα status. Microarray analyses of 31 tumor samples showed 108 genes differentially expressed in ERα (+)...


Article: Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma
Full-text PDFAbstract

Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma     (11/Feb/2010)


A significant group of patient with estrogen receptor (ER) α positive breast tumors fails to appreciably respond to endocrine therapy. An increased understanding of the molecular basis of estrogen-mediated signal transduction and resultant gene expression may lead to novel strategies for treating breast cancer. In this study, we sought to identify the dysregulated genes in breast tumors related to ERα status. Microarray analyses of 31 tumor samples showed 108 genes differentially expressed in ERα (+)...


Article: Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
Full-text PDFAbstract

Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice     (09/Feb/2010)


The immunohistochemistry technique is used in the search for cell or tissue antigens that range from amino acids and proteins to infectious agents and specific cellular populations. The technique comprises two phases: (1) slides preparation and stages involved for the reaction; (2) interpretation and quantification of the obtained expression. Immunohistochemistry is an important tool for scientific research and also a complementary technique for the elucidation of differential diagnoses which are not determinable by conventional analysis...


Abstract
Full-text PDF

Bimodal Gene Expression and Biomarker Discovery     (04/Feb/2010)


With insights gained through molecular profiling, cancer is recognized as a heterogeneous disease with distinct subtypes and outcomes that can be predicted by a limited number of biomarkers. Statistical methods such as supervised classification and machine learning identify distinguishing features associated with disease subtype but are not necessarily clear or...


Abstract
Full-text PDF

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum     (28/Jan/2010)


The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were determined in about 1,700 serum...


Abstract
Full-text PDF

Enhanced Expression of Radiation-Induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility     (22/Dec/2009)


This study was designed to discover blood biomarkers of cancer susceptibility using invasive multiple (n = 21), single primary breast cancer (n = 21), and control subjects (n = 20). Heparinized whole blood was incubated at 37 °C for 2 hours after 0–10 Gy of radiation, then cell cycle arrest...


Abstract
Full-text PDF

Protein Modifications as Potential Biomarkers in Breast Cancer     (30/Nov/2009)


A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current...


Abstract
Full-text PDF

Biomarker Validation for Aging: Lessons from mtDNA Heteroplasmy Analyses in Early Cancer Detection     (27/Nov/2009)


The anticipated biological and clinical utility of biomarkers has attracted significant interest recently. Aging and early cancer detection represent areas active in the search for predictive and prognostic biomarkers. While applications differ, overlapping biological features, analytical technologies and specific biomarker analytes bear comparison. Mitochondrial DNA (mtDNA) as a biomarker in...


Abstract
Full-text PDF

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease     (27/Nov/2009)


Aim: To assess serum Hepatocyte Growth Factor (HGF) levels in autistic children with severe gastrointestinal (GI) disease and to test the hypothesis that there is a relationship between GI pathology and HGF concentration. Subjects and Methods: Serum from 29 autistic children with chronic digestive disease (symptoms for a minimum of 6–12...


Abstract
Full-text PDF

An Optimal Protocol to Analyze the Rat Spinal Cord Proteome     (28/Oct/2009)


Since the function of the spinal cord depends on the proteins found there, better defying the normal Spinal Cord Proteome is an important and challenging task. Although brain and cerebrospinal fluid samples from patients with different central nervous system (CNS) disorders have been studied, a thorough examination of specific spinal...


Abstract
Full-text PDF

Biomarkers of Adiponectin: Plasma Protein Variation and Genomic DNA Polymorphisms     (13/Oct/2009)


Adiponectin is secreted by white adipose tissue and exists as the most abundant adipokine in the human plasma. Recent research has indicated that plasma adiponectin levels are inversely correlated with body mass index (BMI) and insulin resistance. Reduction of plasma adiponectin levels is commonly observed in the patients with type...


Abstract
Full-text PDF

Changes in Plasma IL-6, Plasma VEGF and Serum YKL-40 During Treatment with Etanercept and Methotrexate or Etanercept Alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy     (29/Sep/2009)


Changes in plasma IL-6, plasma VEGF and serum YKL-40 were determined in rheumatoid arthritis (RA) patients during treatment with etanercept alone or in combination with methotrexate. Twenty-five patients with active RA (DAS28 3.2) were randomized to receive etanercept (25 mg sc. biweekly) plus methotrexate (n = 12) or etanercept...


Abstract
Full-text PDF

Growth Factor Receptors and Apoptosis Regulators: Signaling Pathways, Prognosis, Chemosensitivity and Treatment Outcomes of Breast Cancer     (17/Aug/2009)


Biomarkers of breast cancer are necessary for prognosis and prediction to chemotherapy. Prognostic biomarkers provide information regarding outcome irrespective of therapy, while predictive biomarkers provide information regarding response to therapy. Candidate prognostic biomarkers for breast cancers are growth factor receptors, steroid receptors, Ki-67, cyclins, urokinase plasminogen activator, p53, p21, pro-...


Abstract
Full-text PDF

Novel Biomarkers for the Diagnosis of Urinary Tract Infection - A Systematic Review     (05/Aug/2009)


Urinary tract infections (UTIs) are associated with significant morbidity. We rely on clinical presentation, urinalysis, and urine culture to diagnose UTI. To differentiate between lower UTI and pyelonephritis, we depend on the clinical presentation. In the extremes of age and in immunocompromised individuals, clinical presentation is often atypical posing a...


Abstract
Full-text PDF

Joint Variable Selection and Classification with Immunohistochemical Data     (22/Jul/2009)


To determine if candidate cancer biomarkers have utility in a clinical setting, validation using immunohistochemical methods is typically done. Most analyses of such data have not incorporated the multivariate nature of the staining profiles. In this article, we consider modelling such data using recently developed ideas from the machine learning...


Abstract
Full-text PDF

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy     (23/Jun/2009)


Objective: To demonstrate that the administration of an angiotensin (Ang) II type 1 receptor (AT1R) blocker (ARB) inhibits the vicious cycle of high glucose (HG)-reactive oxygen species (ROS)-angiotensinogen (AGT)-Ang II-AT1R-ROS by suppressing ROSs and inflammation, thus ameliorating diabetic nephropathy (DN). Research Design and Methods: Thirteen hypertensive DN patients were administered ARBs,...


Abstract
Full-text PDF

Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection     (06/May/2009)


Background: Acute aortic dissection (AAD) is a life-threatening condition with high mortality and a relatively unclarified pathophysiological mechanism. Although differentially expressed genes in AAD have been recognized, interactions between these genes remain poorly defined. This study was conducted to gain a better understanding of the molecular mechanisms underlying AAD and...


Article: Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types
Full-text PDFAbstract

Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types     (01/May/2009)


Microarray technology has been widely applied to the analysis of many malignancies, however, integrative analyses across multiple studies are rarely investigated. In this study we performed a meta-analysis on the expression profiles of four published studies analyzing organ donor, benign tissues adjacent to tumor and tumor tissues from liver, prostate, lung and bladder samples. We identified 99 distinct multi-cancer biomarkers in the comparison of all three tissues in liver and prostate and 44 in the...